A+ A-

 

Subscribe to our newsletter

 

OFDT's latest enables our English-speaking partners to be updated electronically on our latest publications and ongoing projects throughout the year.


To subscribe to OFDT's latest, please use this online form.
To unsubscribe, please use the appropriate link at the end of a previous newsletter or use this online form.

As part of the General Data Protection Regulation (GDPR), the OFDT informs you that you have the right to access or rectify your data by writing to webmestre@ofdt.fr or to the following address:

OFDT - French Monitoring Centre for Drugs and Drug Addiction
Information and Communication Unit – Internet
69 rue de Varenne
75007 PARIS
FRANCE

The OFDT will keep your email address in its subscriber database for a period of 3 years, unless you decide to unsubscribe, or unless the OFDT receives an automatic message from your mail server ("bounce") indicating that your email address no longer exists, and it is not possible to know your new email address. You can unsubscribe at any time either through a written email or postal request, or online by clicking on the link in the footer of our emails with confirmation via the web page opened via this link. Every 3 years, the OFDT will contact you to ensure that you still want to be registered in our subscriber database.

The personal data you give the OFDT when subscribing are only intended to send you our electronic letter (OFDT’s latest) and are in no way used otherwise or shared with a third party.



Previous OFDT's latest are available here:

- OFDT's latest n° 24 - 12 December 2023: https://sh1.sendinblue.com/ade44ywyv9pfe.html?t=1702481616
- OFDT's latest n° 23 - 29 September 2023: https://ofdt.systalium.eu/lettre/?lettre=174&contact=3486
- OFDT's latest n° 22 - 15 March 2023: https://ofdt.systalium.eu/lettre/?lettre=169&contact=3486
- OFDT's latest n° 21 - 13 October 2022: https://ofdt.systalium.eu/lettre/?lettre=163&contact=3486
- OFDT's latest n° 20 - 16 March 2022: https://ofdt.systalium.eu/lettre/?lettre=140&contact=3486
- OFDT's latest n° 19 - 16 April 2021: https://ofdt.systalium.eu/lettre/?lettre=135&contact=3486
- OFDT's latest n° 18 - 25 November 2020: https://ofdt.systalium.eu/lettre/?lettre=124&contact=3486
- OFDT's latest n° 17 - 26 June 2020: https://ofdt.systalium.eu/lettre/?lettre=119&contact=3486
- OFDT's latest n° 16 - 28 April 2020: https://ofdt.systalium.eu/lettre/?lettre=115&contact=3486
- OFDT's latest n° 15 - 20 January 2020: https://ofdt.systalium.eu/lettre/?lettre=111&contact=3486
- OFDT's latest n° 14 - 13 November 2019: https://ofdt.systalium.eu/lettre/?lettre=110&contact=3486
- OFDT's latest n° 13 - 26 June 2019: https://ofdt.systalium.eu/lettre/?lettre=98&contact=3486
- OFDT's latest n° 12 - 20 December 2018: https://ofdt.systalium.eu/lettre/?lettre=91&contact=3486
- OFDT's latest n° 11 - 26 June 2018: https://ofdt.systalium.eu/lettre/?lettre=82&contact=3486
- OFDT's latest n° 10 - 20 February 2018: https://ofdt.systalium.eu/lettre/?lettre=79&contact=3486
- OFDT's latest n° 9 - 28 November 2017: https://ofdt.systalium.eu/lettre/?lettre=74&contact=3486
- OFDT's latest n° 8 - 27 June 2017: https://ofdt.systalium.eu/lettre/?lettre=69&contact=3486
- OFDT's latest n° 7 - 10 January 2017: https://ofdt.systalium.eu/lettre/?lettre=62&contact=3486
- OFDT's latest n° 6 - 27 June 2016: https://ofdt.systalium.eu/lettre/?lettre=57&contact=3486
- OFDT's latest n° 5 - 18 April 2016: https://ofdt.systalium.eu/lettre/?lettre=52&contact=3486
- OFDT's latest n° 4 - 23 November 2015: https://ofdt.systalium.eu/lettre/?lettre=44&contact=3486
- OFDT's latest n° 3 - 26 June 2015: https://ofdt.systalium.eu/lettre/?lettre=28&contact=1222
- OFDT's latest n° 2 - 19 November 2014: https://ofdt.systalium.eu/lettre/?lettre=16&contact=1222
- OFDT's latest n° 1 - 26 June 2014: https://ofdt.systalium.eu/lettre/?lettre=16&contact=1222

Drugs in Europe


2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.